Study Reveals Crucial Cell and Signaling Pathway that Regulate the Placental Hematopoietic Niche

UCLA stem cell researchers have discovered a critical placental niche cell and signaling pathway that prevent blood precursors from premature differentiation in the placenta, a process necessary for ensuring proper blood supply for an individual’s lifetime.

BSCRC Receives $1 Million Gift to Support Annual Educational Symposium

The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA received a $1 million gift today that will support a popular annual stem cell symposium on the Westwood campus that draws top scientists from around the world.

The Bloomfield Family Foundation, headed by Margaret “Peggy” Bloomfield of Pacific Palisades, made the gift. Bloomfield is a long-time supporter of the Broad Stem Cell Research Center.

BSCRC and JCCC Seminar Featuring Dr. Jonathan Slack

Date: 
03/01/2012

Thursday, March 1, 2012
Time: Noon - 1PM
Room: CNSI Auditorium

Jonathan M.W. Slack, Ph.D., F.Med.Sci.
Director, Stem Cell Institute
University of Minnesota

Talk Title: “Direct Reprogramming to Beta Cells?”

Co-sponsored by
Jonsson Comprehensive Cancer Center
Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research

Light Lunch Served

BSCRC Scientists Explain Neural Cell Breakthrough

In a specially designed facility that is compliant with FDA Good Manufacturing Practices (GMP) requirements, scientists with the Eli and Edythe Center of Regenerative Medicine and Stem Cell Research at UCLA have taken human skin cells, reprogrammed them to be pluripotent and then differentiated them into neurons, using animal origin-free reagents and feeder conditions throughout the process.

UCLA Scientists Find Older, Established Human Embryonic Stem Cell Lines Are Not the Same as Newly Derived Cell Lines

Established human embryonic cell lines, including those approved for federal research funding under former President George W. Bush, are different than newly derived human embryonic stem cell lines, according to a study by UCLA stem cell researchers.

President Obama Nominates Broad Stem Cell Research Center Director Dr. Owen Witte to Serve on the President's Cancer Panel

Dr. Owen Witte, founding director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and a renowned cancer researcher, was selected today by President Barack Obama to serve on the President’s Cancer Panel, which monitors the development and execution of the National Cancer Program.

The members of the panel are selected based on their training, experience and background as exceptionally qualified to appraise the National Cancer Program.

UCLA Scientists Prove that Blood Stem Cells can be Engineered to Produce T-Cells that Seek Out and Attack Melanoma

Researchers from UCLA’s stem cell and cancer centers have demonstrated for the first time that blood stem cells can be engineered to create cancer-killing T-cells that seek out and attack a human melanoma. The researchers believe this approach could be useful in 40 percent of Caucasians with this malignancy.

UCLA Stem Cell Researchers Uncover Mechanism that Regulates Human Pluripotent Stem Cell Metabolism

Human pluripotent stem cells, which can develop into any cell type in the body, rely heavily on glycolysis, or sugar fermentation, to drive their metabolic activities.

In contrast, mature cells in children and adults depend more on cell mitochondria to convert sugar and oxygen into carbon dioxide and water during a high energy-producing process called oxidative phosphorylation for their metabolic needs.

IMED, BSCRC and CTSI Seminar featuring Dr. Gail Martin

Date: 
11/16/2011

Wednesday, November 16, 2011
12:00 – 1:00 PM
Location: NRB Auditorium

Gail Martin, Ph.D.
Professor
Department of Anatomy
University of California, San Francisco

“FGF Signaling in Vertebrate Organogenesis: The Importance of Getting it Right”

Host: Lee Goodglick, Ph.D.
Co-sponsored by: IMED, Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research,
and CTSI

IMED, BSCRC and CTSI Seminar featuring Dr. David Baltimore

Date: 
11/09/2011

Wednesday, November 9, 2011
12:00 – 1:00 PM
Location: NRB Auditorium

David Baltimore, Ph.D.
Nobel Laureate
President Emeritus and Robert Andrews Millikan Professor of Biology
California Institute of Technology

“Post-Transcriptional Control of the Inflammatory Response: Splicing and MicroRNAs”

Host: Lee Goodglick, Ph.D.

Co-sponsored by: IMED, Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research,
and CTSI

Pages